Literature DB >> 7429701

The quantity and distribution of radiolabeled dexamethasone delivered to tissue by iontophoresis.

J M Glass, R L Stephen, S C Jacobson.   

Abstract

A pilot study was conducted in the first of two monkeys using either radiolabeled Dm-Na-P or radiolabeled hydrocortisone sodium succinate, together with lidocaine HCl. This study indicated an approximately tenfold increase in the quantity of Dm-Na-P delivered to the test electrodes (4 mA; 20 minutes) whereas the quantity of hydrocortisone delivered from the test electrodes was only marginally (approximately 10%) increased as compared with that from the controls. In terms of an anti-inflammatory activity, the effective dose of Dm-Na-P in all tissue layers underlying the test electrodes was at least tenfold that of the hydrocortisone. Therefore, further trials with hydrocortisone were abandoned. In the second animal, positive test electrodes (5 mA; 20 minutes, were sited over five joints on the right side of the body and matching control electrodes (0 mA; 20 minutes) were placed over corresponding joints on the left side of the body. The control and test electrodes each contained 1.0 ml tritium-labeled Dm-Na-P (approximately 4.0 mg) and 2.0 ml 4% lidocaine HCl (80 mg). Local tissue concentrations of Dm-Na-P were higher than those that would be obtained by systematic therapy and lower than would be obtained by local injection.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7429701     DOI: 10.1111/j.1365-4362.1980.tb00380.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  15 in total

Review 1.  Optimisation of treatment by applying programmable rate-controlled drug delivery technology.

Authors:  Yie W Chien; Senshang Lin
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Assessment of phonophoresis and iontophoresis in the treatment of carpal tunnel syndrome: a randomized controlled trial.

Authors:  Eda Gurcay; Ece Unlu; Ahmet Gurhan Gurcay; Reyhan Tuncay; Aytul Cakci
Journal:  Rheumatol Int       Date:  2010-12-14       Impact factor: 2.631

3.  Iontophoresis-facilitated delivery of prednisolone through throat skin to the trachea after topical application of its succinate salt.

Authors:  Hiroshi Ishii; Tsukasa Suzuki; Hiroaki Todo; Mitsuhiro Kamimura; Kenji Sugibayashi
Journal:  Pharm Res       Date:  2010-12-23       Impact factor: 4.200

4.  Iontophoretic delivery of nitric oxide donor improves local skin flap viability.

Authors:  John A Russell; Nadine P Connor; Gregory K Hartig
Journal:  J Rehabil Res Dev       Date:  2010

5.  Effectiveness of dexamethasone iontophoresis for temporomandibular joint involvement in juvenile idiopathic arthritis.

Authors:  Rina Mina; Paula Melson; Stephanie Powell; Marepalli Rao; Claas Hinze; Murray Passo; T Brent Graham; Hermine I Brunner
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

6.  Microdialysis and delivery of iontophoresis-driven lidocaine into the human gastrocnemius muscle.

Authors:  Mark Coglianese; David O Draper; Joseph Shurtz; Gary Mark
Journal:  J Athl Train       Date:  2011 May-Jun       Impact factor: 2.860

7.  Absorption of iontophoresis-driven 2% lidocaine with epinephrine in the tissues at 5 mm below the surface of the skin.

Authors:  David O Draper; Mark Coglianese; Chris Castel
Journal:  J Athl Train       Date:  2011 May-Jun       Impact factor: 2.860

Review 8.  Patient-controlled analgesia in the management of postoperative pain.

Authors:  Mona Momeni; Manuela Crucitti; Marc De Kock
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 9.  Steroids versus nonsteroids in the treatment of cutaneous inflammation: therapeutic modalities for office use.

Authors:  E Panconesi; T Lotti
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

Review 10.  Prevention and treatment of overuse tendon injuries.

Authors:  G P Hess; W L Cappiello; R M Poole; S C Hunter
Journal:  Sports Med       Date:  1989-12       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.